The PDI provides integrated early-stage drug development for small-molecule and biologic candidates. Capabilities include formulation development, analytical method development and pre-qualification, accelerated stability studies, and small-scale prototype manufacturing, all under one roof, with preclinical PK/PD expertise available through the College of Pharmacy. As an academic facility, the PDI combines faculty expertise with scientific rigor beyond a typical CRO, making it an ideal partner for early-stage companies.